MAKO Surgical Shares Popped: What You Need to Know (MAKO)

MAKO Surgical Shares Popped: What You Need to Know

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of medical device company MAKO Surgical (Nasdaq: MAKO ) climbed 11% on Monday after its quarterly sales and full-year guidance topped Wall Street expectations.

So what: MAKO sold 18 of its RIO surgical platform systems during the fourth quarter -- versus 13 systems sold in the year-ago period -- suggesting that its technology continues to be adopted at a brisk rate. In fact, a total of 2,258 MAKOplasty procedures were performed during the quarter, representing a whopping 97% jump over the procedures performed during the fourth quarter of 2010.

Now what: Looking ahead to 2012, management expects to sell between 56 and 62 RIO systems and that its customers will perform 11,000 to 13,000 MAKOplasty procedures. "We are pleased with our strong RIO system sales and the interest in our hip application during the fourth quarter," said CEO Maurice Ferre. "In addition, we believe the increased MAKOplasty procedure volume and utilization trends continue to demonstrate the clinical value of our technology." With MAKO shares still down about 25% from October highs, investors might even have time to buy into the optimism.

Interested in more info on MAKO? Add it to your watchlist.

More Expert Advice from The Motley Fool

The Motley Fool's chief investment officer has selected his No. 1 stock for the next year. Find out which stock in our brand-new free report: "The Motley Fool's Top Stock for 2013." I invite you to take a copy, free for a limited time. Just click here to access the report and find out the name of this under-the-radar company.

Jeff Fischer and team have demystified options. And they can rack up income like $1,030... $2,626... and $3,228 on a schedule you can set your watch by!
That's why we're glad to announce every single one of their closely guarded strategies is available to YOU during May and June – 100% FREE, no strings attached! Just enter your email address in the box below...

Fool contributor Brian Pacampara owns no position in any of the companies mentioned. The Motley Fool owns shares of MAKO. Motley Fool newsletter services have recommended buying shares of MAKO. Try any of our Foolish newsletter services free for 30 days.

We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Fool's disclosure policy always gets a perfect score.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment icon found on every comment.